Fenwal Inc recalls Amicus MNC Apheresis Kit Double Needle. Component of Amicus Separator multiprocedural apheresis platform
- Recall date
- February 14, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1254-2023
- FDA classification
- Class II
- Brand / firm
- Fenwal Inc
- Sold / distributed
- Nationwide distribution. International distribution to France, Korea, Taiwan, Colombia, India, Brazil, Germany, Canada.
Why it was recalled
Potential for centrifuge packs to develop a stress leak for certain lots of Amicus MNC Apheresis kit and Amicus Exchange kit (Therapeutic Kits) on the Amicus Separator.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Amicus MNC Apheresis Kit Double Needle. Component of Amicus Separator multiprocedural apheresis platform
Get recall alerts
Free email alert whenever Fenwal Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Fenwal Inc